The existing drug treatments – mainly antipsychotic medications – are only modestly successful in lessening agitation, and they also carry risks of harmful side effects.
The NHS is exploring the possibility of manufacturing medical cannabis products for clinical trials of children who suffer from severe epilepsy. Compounds known as cannabinoids which are found in the cannabis plant have been found to have some anti-seizure potential in certain forms of the condition.
New Mexico’s medical cannabis patients are at risk of running out of medicine due to the effects of COVID-19 and statewide shutdowns, according to a recent report published by O’Donnell Economics.
Sapphire Medical Foundation has announced its first patient has secured medicine funding for one year.
A campaigner has urged the UK government to improve access to medical cannabis prescriptions as restrictive guidance from NICE and the BPNA has meant that no new NHS prescriptions have been written for the last two years.
For any parent to hear a child’s horrific scream as they have a seizure, not breathing or responding, is a rude wakeup call that life will be far from normal.
Nebraska medical marijuana advocates gathered more than 182,000 signatures for an initiative petition campaign, despite challenges stemming from the coronavirus pandemic.
Cannabis and the brain is a hot topic. For much too long, the green, leafy plant was considered to be a catalyst for mental health problems, such as schizophrenia and psychosis.
Australia’s Export Control Amendment (Certificate of Narcotics Exports) Bill 2020 is to improve access to global markets for the nation’s medicinal cannabis and hemp industries.
The mother of a young girl who suffers from a rare form of epilepsy is calling for increased availability of medicinal cannabis on the NHS after revealing her daughter’s struggles without the drug during the Covid-19 lockdown.